• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Performance of the Abbott ID NOW rapid SARS-CoV-2 amplification assay in relation to nasopharyngeal viral RNA loads.

作者信息

Sepulveda Jorge L, Abdulbaki Rami, Sands Zachary, Codoy Maria, Mendoza Salome, Isaacson Nancy, Kochar Olga, Keiser John, Haile-Mariam Tenagne, Meltzer Andrew C, Mores Christopher N, Sepulveda Antonia R

机构信息

Department of Pathology, George Washington University School of Medicine and Health Sciences, United State; Department of Pathology and Laboratory Medicine, George Washington University Hospital, United States.

Department of Pathology and Laboratory Medicine, George Washington University Hospital, United States.

出版信息

J Clin Virol. 2021 Jul;140:104843. doi: 10.1016/j.jcv.2021.104843. Epub 2021 Apr 24.

DOI:10.1016/j.jcv.2021.104843
PMID:33979738
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8091002/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b69/8091002/0c199cfe6f52/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b69/8091002/b9f7e302bc69/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b69/8091002/879b9e951c53/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b69/8091002/0c199cfe6f52/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b69/8091002/b9f7e302bc69/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b69/8091002/879b9e951c53/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b69/8091002/0c199cfe6f52/gr3_lrg.jpg

相似文献

1
Performance of the Abbott ID NOW rapid SARS-CoV-2 amplification assay in relation to nasopharyngeal viral RNA loads.雅培ID NOW快速SARS-CoV-2扩增检测与鼻咽部病毒RNA载量的相关性
J Clin Virol. 2021 Jul;140:104843. doi: 10.1016/j.jcv.2021.104843. Epub 2021 Apr 24.
2
Comparison of abbott ID NOW COVID-19 rapid molecular assay to cepheid xpert xpress SARS-CoV-2 assay in dry nasal swabs.雅培ID NOW新型冠状病毒肺炎快速分子检测法与赛沛Xpert Xpress新型冠状病毒检测法在干燥鼻拭子中的比较。
Diagn Microbiol Infect Dis. 2021 Apr;99(4):115208. doi: 10.1016/j.diagmicrobio.2020.115208. Epub 2020 Sep 16.
3
Performance of Abbott ID Now COVID-19 Rapid Nucleic Acid Amplification Test Using Nasopharyngeal Swabs Transported in Viral Transport Media and Dry Nasal Swabs in a New York City Academic Institution.雅培 ID Now COVID-19 快速核酸扩增检测试剂使用鼻咽拭子和干鼻拭子在纽约市学术机构中运输的病毒运输介质的性能。
J Clin Microbiol. 2020 Jul 23;58(8). doi: 10.1128/JCM.01136-20.
4
Multisite Clinical Validation of Isothermal Amplification-Based SARS-CoV-2 Detection Assays Using Different Sampling Strategies.基于不同采样策略的等温扩增法 SARS-CoV-2 检测分析的多中心临床验证。
Microbiol Spectr. 2021 Oct 31;9(2):e0084621. doi: 10.1128/Spectrum.00846-21. Epub 2021 Oct 20.
5
Saliva is Comparable to Nasopharyngeal Swabs for Molecular Detection of SARS-CoV-2.唾液样本与鼻咽拭子在 SARS-CoV-2 的分子检测中具有可比性。
Microbiol Spectr. 2021 Sep 3;9(1):e0016221. doi: 10.1128/Spectrum.00162-21. Epub 2021 Aug 18.
6
Detection of SARS-CoV-2 RNA in nasopharyngeal swabs from COVID-19 patients and asymptomatic cases of infection by real-time and digital PCR.通过实时荧光定量PCR和数字PCR检测新型冠状病毒肺炎患者及无症状感染者鼻咽拭子中的严重急性呼吸综合征冠状病毒2（SARS-CoV-2）RNA
Klin Lab Diagn. 2020 Dec 29;65(12):785-792. doi: 10.18821/0869-2084-2020-65-12-785-792.
7
Comparative study of four SARS-CoV-2 Nucleic Acid Amplification Test (NAAT) platforms demonstrates that ID NOW performance is impaired substantially by patient and specimen type.四项 SARS-CoV-2 核酸扩增检测（NAAT）平台的比较研究表明，ID NOW 平台的性能受到患者和标本类型的显著影响。
Diagn Microbiol Infect Dis. 2021 Jan;99(1):115200. doi: 10.1016/j.diagmicrobio.2020.115200. Epub 2020 Sep 3.
8
Head-to-head performance comparison of self-collected nasal versus professional-collected nasopharyngeal swab for a WHO-listed SARS-CoV-2 antigen-detecting rapid diagnostic test.自行采集的鼻腔拭子与专业采集的鼻咽拭子用于世界卫生组织清单上的 SARS-CoV-2 抗原检测快速诊断检测的头对头性能比较。
Med Microbiol Immunol. 2021 Aug;210(4):181-186. doi: 10.1007/s00430-021-00710-9. Epub 2021 May 24.
9
Pooling Nasopharyngeal Swab Specimens to Increase Testing Capacity for SARS-CoV-2. pooling 鼻咽拭子标本以增加 SARS-CoV-2 的检测能力。
Med J (Ft Sam Houst Tex). 2021 Jan-Mar(PB 8-21-01/02/03):8-11.
10
Combined SARS-CoV-2 nucleic acid amplification testing and respiratory virus panel RT-PCR on the Hologic Panther Fusion system.基于 Hologic Panther Fusion 系统的 SARS-CoV-2 核酸扩增检测与呼吸道病毒 panel RT-PCR 的联合检测。
J Clin Virol. 2021 May;138:104792. doi: 10.1016/j.jcv.2021.104792. Epub 2021 Mar 10.

引用本文的文献

1
Comparison of an ID NOW COVID-19 Assay Used at the Point of Care to Laboratory-Based Nucleic Acid Amplification Tests.即时 ID NOW COVID-19 检测与基于实验室的核酸扩增检测在床边即时检测中的比较。
J Clin Microbiol. 2023 Jul 20;61(7):e0041323. doi: 10.1128/jcm.00413-23. Epub 2023 Jul 3.
2
Dataset from the comparative evaluation of the STANDARD M10 point-of-care analyzer versus the NeuMoDx assay for the molecular diagnosis of SARS-CoV-2.用于SARS-CoV-2分子诊断的STANDARD M10即时检验分析仪与NeuMoDx检测法的比较评估数据集。
Data Brief. 2022 Dec;45:108690. doi: 10.1016/j.dib.2022.108690. Epub 2022 Oct 21.
3

本文引用的文献

1
Prolonged SARS-CoV-2 cell culture replication in respiratory samples from patients with severe COVID-19.严重 COVID-19 患者呼吸道样本中 SARS-CoV-2 的长时间细胞培养复制。
Clin Microbiol Infect. 2021 Jun;27(6):886-891. doi: 10.1016/j.cmi.2021.02.014. Epub 2021 Feb 22.
2
Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study.西班牙加泰罗尼亚 282 起聚集性 COVID-19 传播：一项队列研究。
Lancet Infect Dis. 2021 May;21(5):629-636. doi: 10.1016/S1473-3099(20)30985-3. Epub 2021 Feb 2.
3
Recommendations for sample pooling on the Cepheid GeneXpert® system using the Cepheid Xpert® Xpress SARS-CoV-2 assay.
Evaluating the Ability to ID (COVID-19) NOW: a Large Real-World Prospective Evaluation of the Abbott ID NOW COVID-19 Assay.
评估当前识别（COVID-19）的能力：雅培 ID NOW COVID-19 检测的大型真实世界前瞻性评估。
Microbiol Spectr. 2022 Jun 29;10(3):e0051322. doi: 10.1128/spectrum.00513-22. Epub 2022 May 17.
4
Diagnostic accuracy of the Abbott ID NOW SARS-CoV-2 rapid test for the triage of acute medical admissions.雅培 ID NOW SARS-CoV-2 快速检测用于急性住院患者分诊的诊断准确性。
J Hosp Infect. 2022 May;123:92-99. doi: 10.1016/j.jhin.2022.02.010. Epub 2022 Feb 23.
使用 Cepheid Xpert® Xpress SARS-CoV-2 检测对 Cepheid GeneXpert® 系统进行样本混合的建议。
PLoS One. 2020 Nov 9;15(11):e0241959. doi: 10.1371/journal.pone.0241959. eCollection 2020.
4
SARS-CoV-2 Viral Load Predicts Mortality in Patients with and without Cancer Who Are Hospitalized with COVID-19.SARS-CoV-2 病毒载量可预测 COVID-19 住院患者的死亡率，无论其是否患有癌症。
Cancer Cell. 2020 Nov 9;38(5):661-671.e2. doi: 10.1016/j.ccell.2020.09.007. Epub 2020 Sep 15.
5
Clinical Sensitivity of Severe Acute Respiratory Syndrome Coronavirus 2 Nucleic Acid Amplification Tests for Diagnosing Coronavirus Disease 2019.严重急性呼吸综合征冠状病毒2核酸扩增检测对诊断2019冠状病毒病的临床敏感性
Open Forum Infect Dis. 2020 Jul 24;7(8):ofaa315. doi: 10.1093/ofid/ofaa315. eCollection 2020 Aug.
6
College of American Pathologists (CAP) Microbiology Committee Perspective: Caution Must Be Used in Interpreting the Cycle Threshold (Ct) Value.美国病理学家学会（CAP）微生物学委员会观点：解读循环阈值（Ct）值时必须谨慎。
Clin Infect Dis. 2021 May 18;72(10):e685-e686. doi: 10.1093/cid/ciaa1199.
7
SARS-CoV-2 viral load predicts COVID-19 mortality.严重急性呼吸综合征冠状病毒2型病毒载量可预测新冠肺炎死亡率。
Lancet Respir Med. 2020 Sep;8(9):e70. doi: 10.1016/S2213-2600(20)30354-4. Epub 2020 Aug 6.
8
SARS-CoV-2 Virus Culture and Subgenomic RNA for Respiratory Specimens from Patients with Mild Coronavirus Disease.SARS-CoV-2 病毒培养及轻症冠状病毒病患者呼吸道标本的亚基因组 RNA
Emerg Infect Dis. 2020 Nov;26(11):2701-2704. doi: 10.3201/eid2611.203219. Epub 2020 Aug 4.
9
Recurrence of positive SARS-CoV-2 viral RNA in recovered COVID-19 patients during medical isolation observation.治愈的 COVID-19 患者在医学隔离观察期间出现 SARS-CoV-2 病毒 RNA 复阳。
Sci Rep. 2020 Jul 17;10(1):11887. doi: 10.1038/s41598-020-68782-w.
10
Impact of Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load on Risk of Intubation and Mortality Among Hospitalized Patients With Coronavirus Disease 2019.严重急性呼吸综合征冠状病毒 2 病毒载量对 2019 年冠状病毒病住院患者插管和死亡率风险的影响。
Clin Infect Dis. 2021 Dec 6;73(11):e4197-e4205. doi: 10.1093/cid/ciaa851.